E. S. Berg

Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial

B. Amundsen, A. Opdahl, K. Sharma, 2022, EBioMedicine.

Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction.

B. Amundsen, A. Opdahl, K. Sharma, 2021, Journal of the American College of Cardiology.

Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant Recipients.

K. Karason, K. Broch, H. Eiskjær, 2024, JACC. Heart failure.

Patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris randomised to an invasive versus conservative strategy: angiographic and procedural results from the After Eighty study

B. Bendz, K. Endresen, M. Abdelnoor, 2020, Open Heart.

Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis

A. Myat, S. Savonitto, N. Morici, 2024, European heart journal.

Long-Term Outcomes of Invasive vs Conservative Strategies for Older Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.

B. Bendz, C. Eek, K. Røysland, 2023, Journal of the American College of Cardiology.